Dublin, Oct. 11, 2023 (GLOBE NEWSWIRE) — The “Automated Microbiology Market, By Type, Diagnostic Technology, End User and Region – Global Forecast 2023-2033” report has been added to ResearchAndMarkets.com Dedication.
The global automated microbiology market size will be US$4.9825 billion in 2022 and is expected to reach US$12.7922 billion by 2033, with a compound annual growth rate of 8.95% during the forecast period of 2023-2033.
Rising number of infectious diseases such as Hepatitis B and C, Hepatitis C, Human Papillomavirus (HPV), and HIV, rising healthcare costs, and improving healthcare infrastructure are some of the factors boosting the market growth. Additionally, rising demand for diagnostic kits, testing reagents, tools, rise in microbial R&D activities, rapid spread of novel coronavirus disease across the globe are other factors supporting market growth. However, a shortage of highly skilled manpower with cutting-edge technologies and the high cost of equipment production are expected to hinder growth.
The increasing number of infectious diseases, including hepatitis B and C, hepatitis C, human papillomavirus (HPV), and HIV, is expected to drive market growth over the forecast period. For example, in August 2022, according to data released by the World Health Organization, more than 1 million people were infected with STDs every day around the world, most of whom were asymptomatic. It also noted that one in four sexually transmitted diseases, such as gonorrhea, chlamydia, trichomoniasis and syphilis, is expected to cause 374 million new infections each year.
Rising demand for COVID-19 related diagnostic kits, testing reagents, tools, and services is expected to drive market growth over the forecast period. For example, in September 2020, ASM began independently collecting clinical laboratory shortage data using Clinical Microbiology Supply Shortage Collection (CMSSC) technology, allowing laboratory directors and active clinical microbiologists to provide without outside interference information received attention.
companies mentioned
- QIAGEN LIMITED.
- Gene Probe Company
- Bio-Rad Laboratories Inc.
- biomerix
- Beckman Coulter
- Agilent Technologies
- Anfei Company
- Abbott Laboratories
- becton dickinson co.
Segmentation: Automated Microbiology Market Report 2022-2033
By Type (Revenue, USD Million), 2022 – 2033
- Automated cultivation system
- instrument
- Reagents
- microbiology analyzer
By Diagnostic Technology (Revenue, USD Million), 2022 – 2033
- DNA sequencing
- Monoclonal antibodies
- DNA and RNA probe technology
- Immunoassay
- radioactive method
- Detection Technology
- non-isotopic methods
By End User (Revenue, USD Million), 2022 – 2033
- Medical Biotechnology Industry
- clinical laboratory
- Hospitals and diagnostic laboratories
- blood bank
By Region (Revenue, USD Million), 2022 – 2033
North America
Europe
- Germany
- France
- U.K.
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East and Africa
- South Africa
- gulf cooperation council
- Rest of MEA
Key attributes:
| Report properties | detail |
| Number of pages | 200 |
| forecast period | 2022-2033 |
| Estimated market value in 2022 (USD) | $4.9825 billion |
| Forecast market value to 2033 (USD) | US$12.7922 billion |
| CAGR | 8.9% |
| Coverage area | Global |
For more information about this report, please visit https://www.researchandmarkets.com/r/4i6dbj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and latest trends.
-
Global Automated Microbiology Market